{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:19:06Z","timestamp":1794507546607,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Characterizing drug\u2013target engagement is essential to understand how small molecules influence cellular functions. Here we present Chem-map for in situ mapping of small molecules that interact with DNA or chromatin-associated proteins, utilizing small-molecule-directed transposase Tn5 tagmentation. We demonstrate Chem-map for three distinct drug-binding modalities as follows: molecules that target a chromatin protein, a DNA secondary structure or that intercalate in DNA. We map the BET bromodomain protein-binding inhibitor JQ1 and provide interaction maps for DNA G-quadruplex structure-binding molecules PDS and PhenDC3. Moreover, we determine the binding sites of the widely used anticancer drug doxorubicin in human leukemia cells; using the Chem-map of doxorubicin in cells exposed to the histone deacetylase inhibitor tucidinostat reveals the potential clinical advantages of this combination therapy. In situ mapping with Chem-map of small-molecule interactions with DNA and chromatin proteins provides insights that will enhance understanding of genome and chromatin function and therapeutic interventions.<\/jats:p>","DOI":"10.1038\/s41587-022-01636-0","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T12:02:44Z","timestamp":1674475364000},"page":"1265-1271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Chem-map profiles drug binding to chromatin in cells"],"prefix":"10.1038","volume":"41","author":[{"given":"Zutao","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7641-1066","authenticated-orcid":false,"given":"Jochen","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Melidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8041-0218","authenticated-orcid":false,"given":"Winnie W. I.","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4132-3573","authenticated-orcid":false,"given":"Xiaoyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4552-2967","authenticated-orcid":false,"given":"Antanas","family":"Radzevi\u010dius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0281-5815","authenticated-orcid":false,"given":"Shankar","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"key":"1636_CR1","unstructured":"Silverman, R.B. & Holladay, M.W. The Organic Chemistry of Drug Design and Drug Action Third Edition (Elsevier, 2014)."},{"key":"1636_CR2","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nchembio.1199","volume":"9","author":"M Schenone","year":"2013","unstructured":"Schenone, M., Dan\u010d\u00edk, V., Wagner, B. K. & Clemons, P. A. Target identification and mechanism of action in chemical biology and drug discovery. Nat. Chem. Biol. 9, 232\u2013240 (2013).","journal-title":"Nat. Chem. Biol."},{"key":"1636_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nbt.2776","volume":"32","author":"L Anders","year":"2014","unstructured":"Anders, L. et al. Genome-wide localization of small molecules. Nat. Biotechnol. 32, 92\u201396 (2014).","journal-title":"Nat. Biotechnol."},{"key":"1636_CR4","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nrg3796","volume":"15","author":"R Rodriguez","year":"2014","unstructured":"Rodriguez, R. & Miller, K. M. Unravelling the genomic targets of small molecules using high-throughput sequencing. Nat. Rev. Genet. 15, 783\u2013796 (2014).","journal-title":"Nat. Rev. Genet."},{"key":"1636_CR5","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1126\/science.aal2066","volume":"356","author":"DS Tyler","year":"2017","unstructured":"Tyler, D. S. et al. Click chemistry enables preclinical evaluation of targeted epigenetic therapies. Science 356, 1397\u20131401 (2017).","journal-title":"Science"},{"key":"1636_CR6","doi-asserted-by":"publisher","first-page":"9235","DOI":"10.1073\/pnas.1404303111","volume":"111","author":"C Jin","year":"2014","unstructured":"Jin, C. et al. Chem-seq permits identification of genomic targets of drugs against androgen receptor regulation selected by functional phenotypic screens. Proc. Natl Acad. Sci. USA 111, 9235\u20139240 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1636_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nchembio.780","volume":"8","author":"R Rodriguez","year":"2012","unstructured":"Rodriguez, R. et al. Small-molecule-induced DNA damage identifies alternative DNA structures in human genes. Nat. Chem. Biol. 8, 301\u2013310 (2012).","journal-title":"Nat. Chem. Biol."},{"key":"1636_CR8","doi-asserted-by":"publisher","first-page":"7584","DOI":"10.1074\/jbc.RA120.013347","volume":"295","author":"CM Vaughn","year":"2020","unstructured":"Vaughn, C. M., Selby, C. P., Yang, Y., Hsu, D. S. & Sancar, A. Genome-wide single-nucleotide resolution of oxaliplatin-DNA adduct repair in drug-sensitive and -resistant colorectal cancer cell lines. J. Biol. Chem. 295, 7584\u20137594 (2020).","journal-title":"J. Biol. Chem."},{"key":"1636_CR9","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1093\/nar\/gky1222","volume":"47","author":"D Sutormin","year":"2018","unstructured":"Sutormin, D., Rubanova, N., Logacheva, M., Ghilarov, D. & Severinov, K. Single-nucleotide-resolution mapping of DNA gyrase cleavage sites across the Escherichia coli genome. Nucleic Acids Res. 47, 1373\u20131388 (2018).","journal-title":"Nucleic Acids Res."},{"key":"1636_CR10","doi-asserted-by":"publisher","first-page":"14246","DOI":"10.1002\/anie.201607380","volume":"55","author":"X Shu","year":"2016","unstructured":"Shu, X., Xiong, X., Song, J., He, C. & Yi, C. Base-resolution analysis of cisplatin-DNA adducts at the genome scale. Angew. Chem. Int. Ed. Engl. 55, 14246\u201314249 (2016).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"1636_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12802-5","volume":"10","author":"WH Gittens","year":"2019","unstructured":"Gittens, W. H. et al. A nucleotide resolution map of Top2-linked DNA breaks in the yeast and human genome. Nat. Commun. 10, 4846 (2019).","journal-title":"Nat. Commun."},{"key":"1636_CR12","doi-asserted-by":"publisher","first-page":"17814","DOI":"10.1021\/ja308888c","volume":"134","author":"JL Meier","year":"2012","unstructured":"Meier, J. L., Yu, A. S., Korf, I., Segal, D. J. & Dervan, P. B. Guiding the design of synthetic DNA-binding molecules with massively parallel sequencing. J. Am. Chem. Soc. 134, 17814\u201317822 (2012).","journal-title":"J. Am. Chem. Soc."},{"key":"1636_CR13","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1002\/cbic.201402497","volume":"15","author":"C Anandhakumar","year":"2014","unstructured":"Anandhakumar, C. et al. Next-generation sequencing studies guide the design of pyrrole-imidazole polyamides with improved binding specificity by the addition of beta-alanine. ChemBioChem 15, 2647\u20132651 (2014).","journal-title":"ChemBioChem"},{"key":"1636_CR14","doi-asserted-by":"publisher","first-page":"E7418","DOI":"10.1073\/pnas.1604847113","volume":"113","author":"GS Erwin","year":"2016","unstructured":"Erwin, G. S. et al. Synthetic genome readers target clustered binding sites across diverse chromatin states. Proc. Natl. Acad. Sci. USA 113, E7418\u2013E7427 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1636_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09982-5","volume":"10","author":"HS Kaya-Okur","year":"2019","unstructured":"Kaya-Okur, H. S. et al. CUT&Tag for efficient epigenomic profiling of small samples and single cells. Nat. Commun. 10, 1930 (2019).","journal-title":"Nat. Commun."},{"key":"1636_CR16","doi-asserted-by":"publisher","first-page":"15758","DOI":"10.1021\/ja805615w","volume":"130","author":"R Rodriguez","year":"2008","unstructured":"Rodriguez, R. et al. A novel small molecule that alters shelterin integrity and triggers a DNA-damage response at telomeres. J. Am. Chem. Soc. 130, 15758\u201315759 (2008).","journal-title":"J. Am. Chem. Soc."},{"key":"1636_CR17","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1021\/ja067352b","volume":"129","author":"A De Cian","year":"2007","unstructured":"De Cian, A., Delemos, E., Mergny, J. L., Teulade-Fichou, M. P. & Monchaud, D. Highly efficient G-quadruplex recognition by bisquinolinium compounds. J. Am. Chem. Soc. 129, 1856\u20131857 (2007).","journal-title":"J. Am. Chem. Soc."},{"key":"1636_CR18","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/ng.3662","volume":"48","author":"R H\u00e4nsel-Hertsch","year":"2016","unstructured":"H\u00e4nsel-Hertsch, R. et al. G-quadruplex structures mark human regulatory chromatin. Nat. Genet. 48, 1267 (2016).","journal-title":"Nat. Genet."},{"key":"1636_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nchem.1548","volume":"5","author":"G Biffi","year":"2013","unstructured":"Biffi, G., Tannahill, D., McCafferty, J. & Balasubramanian, S. Quantitative visualization of DNA G-quadruplex structures in human cells. Nat. Chem. 5, 182\u2013186 (2013).","journal-title":"Nat. Chem."},{"key":"1636_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.trechm.2019.07.002","volume":"2","author":"J Spiegel","year":"2020","unstructured":"Spiegel, J., Adhikari, S. & Balasubramanian, S. The structure and function of DNA G-quadruplexes. Trends Chem. 2, 123\u2013136 (2020).","journal-title":"Trends Chem."},{"key":"1636_CR21","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/nchem.842","volume":"2","author":"S M\u00fcller","year":"2010","unstructured":"M\u00fcller, S., Kumari, S., Rodriguez, R. & Balasubramanian, S. Small-molecule-mediated G-quadruplex isolation from human cells. Nat. Chem. 2, 1095\u20131098 (2010).","journal-title":"Nat. Chem."},{"key":"1636_CR22","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41557-020-0506-4","volume":"12","author":"M Di Antonio","year":"2020","unstructured":"Di Antonio, M. et al. Single-molecule visualization of DNA G-quadruplex formation in live cells. Nat. Chem. 12, 832\u2013837 (2020).","journal-title":"Nat. Chem."},{"key":"1636_CR23","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/nbt.3295","volume":"33","author":"VS Chambers","year":"2015","unstructured":"Chambers, V. S. et al. High-throughput sequencing of DNA G-quadruplex structures in the human genome. Nat. Biotechnol. 33, 877 (2015).","journal-title":"Nat. Biotechnol."},{"key":"1636_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-02943-3","volume":"11","author":"WWI Hui","year":"2021","unstructured":"Hui, W. W. I., Simeone, A., Zyner, K. G., Tannahill, D. & Balasubramanian, S. Single-cell mapping of DNA G-quadruplex structures in human cancer cells. Sci Rep. 11, 23641 (2021).","journal-title":"Sci Rep."},{"key":"1636_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10577-015-9509-1","volume":"24","author":"L Baranello","year":"2016","unstructured":"Baranello, L., Kouzine, F., Sanford, S. & Levens, D. ChIP bias as a function of cross-linking time. Chromosome Res. 24, 175\u2013181 (2016).","journal-title":"Chromosome Res."},{"key":"1636_CR26","doi-asserted-by":"publisher","first-page":"15182","DOI":"10.1073\/pnas.1922072117","volume":"117","author":"X Qiao","year":"2020","unstructured":"Qiao, X. et al. Uncoupling DNA damage from chromatin damage to detoxify doxorubicin. Proc. Natl Acad. Sci. USA 117, 15182\u201315192 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1636_CR27","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s11095-014-1557-2","volume":"32","author":"C Di Meo","year":"2015","unstructured":"Di Meo, C. et al. Polyaspartamide-doxorubicin conjugate as potential prodrug for anticancer therapy. Pharm. Res. 32, 1557\u20131569 (2015).","journal-title":"Pharm. Res."},{"key":"1636_CR28","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1021\/bi00462a016","volume":"29","author":"CA Frederick","year":"1990","unstructured":"Frederick, C. A. et al. Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin. Biochemistry 29, 2538\u20132549 (1990).","journal-title":"Biochemistry"},{"key":"1636_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02346-7","volume":"22","author":"J Shen","year":"2021","unstructured":"Shen, J. et al. Promoter G-quadruplex folding precedes transcription and is controlled by chromatin. Genome Biol. 22, 143 (2021).","journal-title":"Genome Biol."},{"key":"1636_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.mrfmmm.2015.01.007","volume":"773","author":"F Yang","year":"2015","unstructured":"Yang, F., Kemp, C. J. & Henikoff, S. Anthracyclines induce double-strand DNA breaks at active gene promoters. Mutat. Res. 773, 9\u201315 (2015).","journal-title":"Mutat. Res."},{"key":"1636_CR31","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/sj.bjc.6605293","volume":"101","author":"PN Munster","year":"2009","unstructured":"Munster, P. N. et al. Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker. Br. J. Cancer 101, 1044\u20131050 (2009).","journal-title":"Br. J. Cancer"},{"key":"1636_CR32","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1158\/1078-0432.CCR-19-2152","volume":"26","author":"K Vu","year":"2020","unstructured":"Vu, K. et al. Romidepsin plus liposomal doxorubicin is safe and effective in patients with relapsed or refractory T-cell lymphoma: results of a phase I dose-escalation study. Clin. Cancer Res. 26, 1000\u20131008 (2020).","journal-title":"Clin. Cancer Res."},{"key":"1636_CR33","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1039\/C4MD00350K","volume":"5","author":"D Pan","year":"2014","unstructured":"Pan, D. et al. Discovery of an orally active subtype-selective HDAC inhibitor, chidamide, as an epigenetic modulator for cancer treatment. MedChemComm 5, 1789\u20131796 (2014).","journal-title":"MedChemComm"},{"key":"1636_CR34","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1093\/annonc\/mdv237","volume":"26","author":"Y Shi","year":"2015","unstructured":"Shi, Y. et al. Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma. Ann. Oncol. 26, 1766\u20131771 (2015).","journal-title":"Ann. Oncol."},{"key":"1636_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-020-00948-9","volume":"12","author":"M Zhang","year":"2020","unstructured":"Zhang, M. et al. Clinical efficacy and molecular biomarkers in a phase II study of tucidinostat plus R-CHOP in elderly patients with newly diagnosed diffuse large B-cell lymphoma. Clin. Epigenetics 12, 160 (2020).","journal-title":"Clin. Epigenetics"},{"key":"1636_CR36","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1038\/s41596-020-0373-x","volume":"15","author":"HS Kaya-Okur","year":"2020","unstructured":"Kaya-Okur, H. S., Janssens, D. H., Henikoff, J. G., Ahmad, K. & Henikoff, S. Efficient low-cost chromatin profiling with CUT&Tag. Nat. Protoc. 15, 3264\u20133283 (2020).","journal-title":"Nat. Protoc."},{"key":"1636_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nrd.2016.268","volume":"16","author":"A Beck","year":"2017","unstructured":"Beck, A., Goetsch, L., Dumontet, C. & Corva\u00efa, N. Strategies and challenges for the next generation of antibody-drug conjugates. Nat. Rev. Drug Discov. 16, 315\u2013337 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1636_CR38","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.1039\/D2CS00193D","volume":"51","author":"K Li","year":"2022","unstructured":"Li, K. & Crews, C. M. PROTACs: past, present and future. Chem. Soc. Rev. 51, 5214\u20135236 (2022).","journal-title":"Chem. Soc. Rev."},{"key":"1636_CR39","doi-asserted-by":"publisher","first-page":"6483","DOI":"10.1002\/anie.201701144","volume":"56","author":"E Zacharioudakis","year":"2017","unstructured":"Zacharioudakis, E. et al. Chromatin regulates genome targeting with cisplatin. Angew. Chem. Int. Ed. 56, 6483\u20136487 (2017).","journal-title":"Angew. Chem. Int. Ed."},{"key":"1636_CR40","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nature14590","volume":"523","author":"JD Buenrostro","year":"2015","unstructured":"Buenrostro, J. D. et al. Single-cell chromatin accessibility reveals principles of regulatory variation. Nature 523, 486\u2013490 (2015).","journal-title":"Nature"},{"key":"1636_CR41","doi-asserted-by":"publisher","first-page":"W160","DOI":"10.1093\/nar\/gkw257","volume":"44","author":"F Ram\u00edrez","year":"2016","unstructured":"Ram\u00edrez, F. et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 44, W160\u2013W165 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1636_CR42","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature10730","volume":"481","author":"CS Ross-Innes","year":"2012","unstructured":"Ross-Innes, C. S. et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 481, 389\u2013393 (2012).","journal-title":"Nature"},{"key":"1636_CR43","unstructured":"Stark, R. & Brown, G. DiffBind: differential binding analysis of ChIP-Seq peak data. http:\/\/bioconductor.org\/packages\/release\/bioc\/vignettes\/DiffBind\/inst\/doc\/DiffBind.pdf (2011)."},{"key":"1636_CR44","doi-asserted-by":"crossref","unstructured":"Yu, Z. et al. Chem-map profiles drug binding to chromatin in cells. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE209713 (2022).","DOI":"10.1038\/s41587-022-01636-0"},{"key":"1636_CR45","doi-asserted-by":"crossref","unstructured":"Yu, Z. et al. Chem-map profiles drug binding to chromatin in cells. https:\/\/github.com\/sblab-bioinformatics\/Chem-map (2022).","DOI":"10.1038\/s41587-022-01636-0"}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41587-022-01636-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-022-01636-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-022-01636-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T17:02:10Z","timestamp":1694538130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41587-022-01636-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["1636"],"URL":"https:\/\/doi.org\/10.1038\/s41587-022-01636-0","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742506685.793598553","asserted-by":"object"}]},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,23]]},"assertion":[{"value":"17 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.B. is a founder and shareholder of Cambridge Epigenetix and Inflex. J.S. is an employee of Inflex. The other authors declare no conflicts of interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}